Tag: Lotte Biologics

Lotte Biologics

Latest News

Lotte Biologics, Rakuten Medical sign deal on producing new cancer treatment drug

Lotte Biologics signed a contract manufacturing organization (CMO) agreement with Rakuten Medical on Tuesday to produce and commercialize Rakuten’s photoimmunotherapy (PIT) drug, an antibody-dye conjugate used in the treatment of cancer.

2026.1.14

Lotte Group Chairman Shin Dong-bin inspects the ADC production facility at Lotte Biologics’ Syracuse bio campus in New York on Oct. 5. [LOTTE GROUP]

Lotte Group chief makes first inspection tour of U.S. bio campus since 2023 acquisition

Lotte Group Chairman Shin Dong-bin visited the group’s U.S. biopharmaceutical hub in Syracuse, New York, on Sunday, marking his first inspection of the site since its acquisition in 2023.

2025.10.9

Most popular

Samsung Biologics' factory in Songdo, Incheon [SAMSUNG BIOLOGICS]

Samsung Biologics inks $1.29 billion deal as Korean biotech firms scramble amid Trump tariff threat

Samsung Biologics secured a $1.29 billion contract with a U.S. pharmaceutical firm, boosting cumulative orders this year to 5.24 trillion won. Companies like Lotte Biologics and Celltrion also reported significant contracts amid tariff concerns.

2025.9.9

From right, Brett Budis, head of global PMO at Lotte Biologics; Shin Yoo-Yeol, head of global strategy; James Park, CEO of Lotte Biologics; and executives from Ottimo Pharma pose for a photo after a signing ceremony held at Lotte Biologics' booth for 2025 BIO International Convention in Boston on June 18. [LOTTE BIOLOGICS]

Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate

BOSTON — Lotte Biologics signed a contract manufacturing agreement with U.K.-based biotech company Ottimo Pharma for its production of a novel antibody drug candidate known as Jankistomig, the Korean firm said on Wednesday.

2025.6.19

Lotte Biologics CEO James Park speaks during a presentation at the 43rd J.P. Morgan Healthcare Conference held in San Francisco, California, on Jan. 16. [LEE JAE-LIM]

Lotte outlines ambitious U.S. plans for ADC, CDMO businesses

Lotte Biologics has ambitious plans for its antibody-drug conjugate and contract development and manufacturing organization businesses.

2025.1.17

Lotte Biologics names new CEO in pursuit of market expansion

Lotte Biologics tapped James Park, former CEO of GC Cell, as its new leader on Monday, with an aim to expand its global market presence.

2024.12.2

Lotte Biologics held a ground-breaking ceremony for the Songdo Bio Campus on July 3. [Lotte Group]

Lotte drives industry change with AI integration, new growth themes

Lotte is looking toward more industry innovation with the proactive adoption of AI across the group’s array of businesses. The intent is to go beyond enhancing efficiency to strengthen corporate competitive advantage. Moreover, Lotte is preparing...

2024.7.31

Lotte Chairman Shin Dong-bin, sixth from left, poses for a photo during a groundbreaking ceremony for the first plant on Lotte Biologics' Songdo Bio Campus in Incheon, along with other attendees including Lotte Biologics CEO Richard Lee, third from right, on Wednesday. [LOTTE BIOLOGICS]

Lotte Biologics expands capacity with new 360,000-liter Songdo plant

Lotte Biologics began construction on its 360,000-liter production site in Songdo, Incheon.

2024.7.3

A computer-generated image of Lotte Biologics' 360,000-liter production plants, which will be built in Songdo, Incheon [LOTTE BIOLOGICS]

Lotte Corporation to pour 120 billion won into Lotte Biologics for Incheon production plant

Lotte Corporation will funnel 120 billion won ($86.4 million) into Lotte Biologics for the biopharmaceutical contract manufacturer’s upcoming production plant in Incheon.

2024.6.25

Lotte Biologics CEO Richard Lee, left, and Sebastian Arana, head of Process Solutions at Merck, shake hands during a letter of agreement signing ceremony. [LOTTE BIOLOGICS]

Lotte Biologics signs manufacturing agreement with chemical firm Merck

Lotte Biologics and Merck, a German chemical and technology giant, signed an agreement for a strategic collaboration in biomanufacturing.

2024.5.31